Lexicon Pharmaceuticals (LXRX) Stock Insights

LXRX price $1.45 -0.03 -1.70%

Ticker
LXRX
Price
$1.45
Change
-0.03 -1.70%
Market cap ?
$647.32M
Beta ?
1.08
Sector
Healthcare
Industry
Biotechnology

Fair value

LXRX fair value $0.52. Price $1.45. Price is 182% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 11.48M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.23% (beta 1.1). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 444.96M. Net debt 27.91M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare LXRX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.06—4.14M
2026-08-06-0.06-0.05692.00K3.99M
2026-05-07-0.00-0.0421.10M9.79M
2026-03-05-0.04-0.075.49M3.14M
2025-11-06-0.04-0.0714.18M3.14M
2025-08-060.01-0.0828.87M5.81M
2025-05-13-0.07-0.101.26M1.31M
2025-03-06-0.09-0.1126.55M2.82M
2024-11-12-0.18-0.171.75M6.48M
2024-08-01-0.17-0.181.65M8.16M
2024-05-02-0.20-0.181.13M1.40M
2024-03-11-0.20-0.23702.00K1.24M
2023-11-08-0.21-0.22162.00K4.79M
2023-08-03-0.22-0.17317.00K4.06M
2023-05-02-0.17-0.1724.00K30.00K
2023-03-02-0.16-0.1428.00K50.00K
2022-11-09-0.13-0.1539.00K50.00K
2022-08-02-0.16-0.1535.00K100.00K
2022-05-05-0.16-0.1637.00K50.00K
2022-02-28-0.17-0.1714.00K14.78K
2021-11-03-0.16-0.1823.00K120.00K
2021-07-30-0.13-0.16234.00K10.00K
2021-05-06-0.15-0.1727.00K110.00K
2021-03-10-0.05-0.28199.00K—
2020-10-290.700.266.63M8.71M
2020-07-30-0.64-0.579.16M8.60M
2020-04-27-0.63-0.668.00M8.76M
2020-03-12-0.48-0.768.73M12.83M
2019-11-072.110.73294.45M110.23M
2019-07-31-0.22-0.099.68M3.52M
2019-05-01-0.21-0.219.22M9.65M
2019-03-13-0.16-0.2817.07M31.52M
2018-11-01-0.26-0.326.86M8.84M
2018-07-30-0.33-0.3513.75M14.22M
2018-05-03-0.40-0.4225.21M28.57M
2018-02-22-0.31-0.4333.05M52.24M
2017-11-08-0.29-0.3626.94M33.39M
2017-08-01-0.33-0.4512.05M16.13M
2017-05-02-0.31-0.4418.29M23.29M
2017-03-03-0.31-0.5123.04M31.87M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-03Swain Judith LBuy89.31K——
2026-06-03Swain Judith LSell89.31K——
2026-06-03Sullivan Diane E.Buy89.31K——
2026-06-03Sullivan Diane E.Sell89.31K——
2026-06-03SOBECKI CHRISTOPHER JBuy89.31K——
2026-06-03SOBECKI CHRISTOPHER JSell89.31K——
2026-06-03Cheung IvanBuy89.31K——
2026-06-03Cheung IvanSell89.31K——
2026-06-03BARKER SAM LBuy89.31K——
2026-06-03BARKER SAM LSell89.31K——
2026-06-03Amouyal PhilippeBuy89.31K——
2026-06-03Amouyal PhilippeSell89.31K——
2026-06-03DEBBANE RAYMONDBuy89.31K——
2026-06-03DEBBANE RAYMONDSell89.31K——
2026-05-01Amouyal PhilippeBuy43.48K$1.6170.00K
2026-05-01Amouyal PhilippeBuy35.71K——
2026-05-01SOBECKI CHRISTOPHER JBuy43.48K$1.6170.00K
2026-05-01SOBECKI CHRISTOPHER JBuy35.71K——
2026-05-01BARKER SAM LBuy43.48K$1.6170.00K
2026-05-01BARKER SAM LBuy35.71K——
2026-05-01Cheung IvanBuy43.48K$1.6170.00K
2026-05-01Cheung IvanBuy35.71K——
2026-05-01Swain Judith LBuy43.48K$1.6170.00K
2026-05-01Swain Judith LBuy35.71K——
2026-05-01Sullivan Diane E.Buy43.48K$1.6170.00K
2026-05-01Sullivan Diane E.Buy35.71K——
2026-05-01DEBBANE RAYMONDBuy43.48K$1.6170.00K
2026-05-01DEBBANE RAYMONDBuy35.71K——
2026-04-30Artal Participations S.a r.l.Buy20.42M——
2026-04-30Artal Participations S.a r.l.Buy408.43K——
2026-04-30Artal Participations S.a r.l.Sell408.43K——
2026-02-28McDermott WendyBuy144.39K——
2026-02-28McDermott WendySell144.39K——
2026-02-28McDermott WendySell68.11K$1.47100.12K
2026-02-28McDermott WendyBuy52.32K——
2026-02-28McDermott WendyBuy27.70K——
2026-02-28McDermott WendySell52.32K——
2026-02-28McDermott WendySell27.70K——
2026-02-28Martens Rachel YapSell67.09K——
2026-02-28Martens Rachel YapBuy67.09K——
2026-02-28Martens Rachel YapSell35.83K$1.4752.66K
2026-02-28Granowitz Craig BBuy202.26K——
2026-02-28Granowitz Craig BSell202.26K——
2026-02-28Granowitz Craig BSell109.10K$1.47160.37K
2026-02-28Granowitz Craig BBuy74.23K——
2026-02-28Granowitz Craig BBuy35.79K——
2026-02-28Granowitz Craig BSell74.23K——
2026-02-28Granowitz Craig BSell35.79K——
2026-02-28Gopinathan SumaBuy65.64K——
2026-02-28Gopinathan SumaSell24.34K$1.4735.78K
2026-02-28Gopinathan SumaSell65.64K——
2026-02-28Gopinathan SumaBuy20.31K——
2026-02-28Gopinathan SumaBuy14.00K——
2026-02-28Gopinathan SumaSell20.31K——
2026-02-28Gopinathan SumaSell14.00K——
2026-02-28DeFrancesco LisaSell128.19K——
2026-02-28DeFrancesco LisaBuy128.19K——
2026-02-28DeFrancesco LisaSell74.57K$1.47109.62K
2026-02-28DeFrancesco LisaBuy24.67K——
2026-02-28DeFrancesco LisaSell24.67K——
2026-02-28Crum Brian TBuy170.16K——
2026-02-28Crum Brian TSell105.02K$1.47154.38K
2026-02-28Crum Brian TBuy33.46K——
2026-02-28Crum Brian TSell170.16K——
2026-02-28Crum Brian TBuy69.39K——
2026-02-28Crum Brian TSell69.39K——
2026-02-28Crum Brian TSell33.46K——
2026-02-28Coiante Scott MSell160.24K——
2026-02-28Coiante Scott MBuy160.24K——
2026-02-28Coiante Scott MSell54.88K$1.4780.68K
2026-02-28Exton MichaelSell503.26K——
2026-02-28Exton MichaelBuy503.26K——
2026-02-28Exton MichaelSell204.83K$1.47301.10K
2026-02-25DEBBANE RAYMONDBuy2.00K$1.492.98K
2026-02-23DEBBANE RAYMONDBuy100.00K$1.47147.00K
2026-02-20DEBBANE RAYMONDBuy100.00K$1.48147.79K
2026-02-19DEBBANE RAYMONDBuy50.00K$1.4471.97K
2026-02-18DEBBANE RAYMONDBuy133.69K$1.32176.47K
2026-02-17Artal Participations S.a r.l.Buy41.29K$65.002.68M
2026-02-17DEBBANE RAYMONDBuy76.86K$1.31100.54K
2026-02-13DEBBANE RAYMONDBuy57.95K$1.3175.88K
2026-02-12McDermott WendyBuy375.30K$1.37514.16K
2026-02-12McDermott WendyBuy250.20K——
2026-02-12Martens Rachel YapBuy290.62K$1.37398.15K
2026-02-12Martens Rachel YapBuy193.74K——
2026-02-12Granowitz Craig BBuy519.92K$1.37712.29K
2026-02-12Granowitz Craig BBuy346.61K——
2026-02-12Gopinathan SumaBuy357.68K$1.37490.02K
2026-02-12Gopinathan SumaBuy238.45K——
2026-02-12DeFrancesco LisaBuy386.30K$1.37529.23K
2026-02-12DeFrancesco LisaBuy257.53K——
2026-02-12Crum Brian TBuy449.56K$1.37615.90K
2026-02-12Crum Brian TBuy299.71K——
2026-02-12Coiante Scott MBuy409.02K$1.37560.36K
2026-02-12Coiante Scott MBuy272.68K——
2026-02-12Exton MichaelBuy1.29M$1.371.77M
2026-02-12Exton MichaelBuy862.44K——
2026-02-02Avicenna Life Sci Master Fund LPOther0——
2026-02-02Invus Global Management, LLCBuy18.55M$1.3024.12M
2026-02-02Invus Global Management, LLCBuy3.85M$1.305.00M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 156, holders +15 vs prior quarter. Ownership 91.59%.

HolderSharesChangeChange %Value
ARTAL GROUP S.A.175.16M20.42M+13.20%420.37M
FMR LLC51.78M6.73M+14.93%124.28M
SIREN, L.L.C.44.30M00.00%106.33M
SESSA CAPITAL IM, L.P.18.96M1.05M+5.85%45.51M
BLACKROCK, INC.17.35M14.03M+422.20%41.64M
VANGUARD CAPITAL MANAGEMENT LLC9.90M382.04K+4.01%23.76M
POINT72 ASSET MANAGEMENT, L.P.8.25M436.72K+5.59%19.80M
GEODE CAPITAL MANAGEMENT, LLC6.24M3.08M+97.04%14.99M
STATE STREET CORP4.92M3.95M+410.12%11.80M
VANGUARD PORTFOLIO MANAGEMENT LLC2.36M1.81M+331.35%5.66M
NORTHERN TRUST CORP1.97M1.47M+297.97%4.72M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.96M1.96MNew4.70M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.96M645.48K+49.22%4.70M
VANGUARD FIDUCIARY TRUST CO1.63M302.29K+22.69%3.92M
CITADEL ADVISORS LLC1.60M1.56M+3933.20%3.84M
ISHARA INVESTMENTS LP1.27M369.00K+40.91%3.05M
MILLENNIUM MANAGEMENT LLC1.13M-3.81M-77.06%2.72M
RENAISSANCE TECHNOLOGIES LLC1.13M-473.50K-29.58%2.70M
MACKENZIE FINANCIAL CORP963.35K190.68K+24.68%2.31M
ADAR1 CAPITAL MANAGEMENT, LLC750.00K00.00%1.80M
SUSQUEHANNA INTERNATIONAL GROUP, LLP696.78K612.38K+725.56%1.67M
ACADIAN ASSET MANAGEMENT LLC696.62K251.33K+56.44%1.67M
UBS GROUP AG684.71K-1.80M-72.43%1.64M
SUSQUEHANNA INTERNATIONAL GROUP, LLP668.50K584.10K+692.06%1.60M
TWO SIGMA INVESTMENTS, LP643.44K-556.19K-46.36%1.54M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Lexicon Pharmaceuticals (LXRX) Stock Insights

LXRX$1.45-0.03 -1.70%

$647.32M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History